Literature DB >> 23468498

Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses.

Waleed H Mahallawi1, Anand V Kasbekar, Maxwell S McCormick, Katja Hoschler, Nigel Temperton, Samuel C Leong, Helen Beer, Francesca Ferrara, Paul S McNamara, Qibo Zhang.   

Abstract

Influenza is a highly contagious mucosal infection in the respiratory tract. The 2009 pandemic H1N1 (pH1N1) influenza virus infection resulted in substantial morbidity and mortality in humans. Little is known on whether immunological memory develops following pH1N1 infection and whether it provides protection against other virus subtypes. An enzyme-linked immunosorbent spot assay was used to analyze hemagglutinin (HA)-specific memory B cell responses after virus antigen stimulation in nose-associated lymphoid tissues (NALT) from children and adults. Individuals with serological evidence of previous exposure to pH1N1 showed significant cross-reactive HA-specific memory B cell responses to pH1N1, seasonal H1N1 (sH1N1), and avian H5N1 (aH5N1) viruses upon pH1N1 virus stimulation. pH1N1 virus antigen elicited stronger cross-reactive memory B cell responses than sH1N1 virus. Intriguingly, aH5N1 virus also activated cross-reactive memory responses to sH1N1 and pH1N1 HAs in those who had previous pH1N1 exposure, and that correlated well with the memory response stimulated by pH1N1 virus antigen. These memory B cell responses resulted in cross-reactive neutralizing antibodies against sH1N1, 1918 H1N1, and aH5N1 viruses. The 2009 pH1N1 infection appeared to have primed human host with B cell memory in NALT that offers cross-protective mucosal immunity to not only H1N1 but also aH5N1 viruses. These findings may have important implications for future vaccination strategies against influenza. It will be important to induce and/or enhance such cross-protective mucosal memory B cells.

Entities:  

Mesh:

Year:  2013        PMID: 23468498      PMCID: PMC3648155          DOI: 10.1128/JVI.03547-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children.

Authors:  A Nurkka; J MacLennan; V Jäntti; S Obaro; B Greenwood; H Käyhty
Journal:  Vaccine       Date:  2000-10-15       Impact factor: 3.641

2.  Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Authors:  Shane Crotty; Phil Felgner; Huw Davies; John Glidewell; Luis Villarreal; Rafi Ahmed
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

3.  Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.

Authors:  M Korkeila; H Lehtonen; H Ahman; O Leroy; J Eskola; H Käyhty
Journal:  Vaccine       Date:  2000-01-18       Impact factor: 3.641

4.  Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.

Authors:  Gui-Mei Li; Christopher Chiu; Jens Wrammert; Megan McCausland; Sarah F Andrews; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Xinyan Qu; Srilatha Edupuganti; Mark Mulligan; Suman R Das; Jonathan W Yewdell; Aneesh K Mehta; Patrick C Wilson; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

5.  Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children.

Authors:  Qibo Zhang; Sharon Choo; Adam Finn
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

Authors:  Balaji Manicassamy; Rafael A Medina; Rong Hai; Tshidi Tsibane; Silke Stertz; Estanislao Nistal-Villán; Peter Palese; Christopher F Basler; Adolfo García-Sastre
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

7.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

8.  Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

Authors:  Xiaocong Yu; Tshidi Tsibane; Patricia A McGraw; Frances S House; Christopher J Keefer; Mark D Hicar; Terrence M Tumpey; Claudia Pappas; Lucy A Perrone; Osvaldo Martinez; James Stevens; Ian A Wilson; Patricia V Aguilar; Eric L Altschuler; Christopher F Basler; James E Crowe
Journal:  Nature       Date:  2008-08-17       Impact factor: 49.962

9.  Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.

Authors:  Surender Khurana; Amorsolo L Suguitan; Yonaira Rivera; Cameron P Simmons; Antonio Lanzavecchia; Federica Sallusto; Jody Manischewitz; Lisa R King; Kanta Subbarao; Hana Golding
Journal:  PLoS Med       Date:  2009-04-21       Impact factor: 11.069

10.  A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.

Authors:  Nigel J Temperton; Katja Hoschler; Diane Major; Carolyn Nicolson; Ruth Manvell; Vo Minh Hien; Do Quang Ha; Menno de Jong; Maria Zambon; Yasuhiro Takeuchi; Robin A Weiss
Journal:  Influenza Other Respir Viruses       Date:  2007-05       Impact factor: 4.380

View more
  10 in total

1.  Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Authors:  Hillary A Vanderven; Lu Liu; Fernanda Ana-Sosa-Batiz; Thi Ho Nguyen; Yanmin Wan; Bruce Wines; P Mark Hogarth; Danielle Tilmanis; Arnold Reynaldi; Matthew S Parsons; Aeron C Hurt; Miles P Davenport; Tom Kotsimbos; Allen C Cheng; Katherine Kedzierska; Xiaoyan Zhang; Jianqing Xu; Stephen J Kent
Journal:  JCI Insight       Date:  2017-07-06

2.  Refining the approach to vaccines against influenza A viruses with pandemic potential.

Authors:  Rita Czako; Kanta Subbarao
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

Review 3.  Pseudotype-based neutralization assays for influenza: a systematic analysis.

Authors:  George William Carnell; Francesca Ferrara; Keith Grehan; Craig Peter Thompson; Nigel James Temperton
Journal:  Front Immunol       Date:  2015-04-29       Impact factor: 7.561

4.  Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.

Authors:  Abdullah Aljurayyan; Suttida Puksuriwong; Muhammad Ahmed; Ravi Sharma; Madhan Krishnan; Salil Sood; Katherine Davies; Devika Rajashekar; Sam Leong; Paul S McNamara; Stephen Gordon; Qibo Zhang
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

5.  Assessment of the influenza vaccine (VAXIGRIP) in triggering a humoural immune response.

Authors:  Waleed H Mahallawi
Journal:  J Taibah Univ Med Sci       Date:  2017-02-20

6.  In vitro cell culture model of human nasal-associated lymphoid tissue (NALT) to evaluate the humoral immune response to SARS-CoV-2 spike proteins.

Authors:  Waleed H Mahallawi; Talal M Aljeraisi
Journal:  Saudi J Biol Sci       Date:  2021-04-24       Impact factor: 4.219

7.  Lung-resident memory B cells protect against bacterial pneumonia.

Authors:  Kimberly A Barker; Neelou S Etesami; Anukul T Shenoy; Emad I Arafa; Carolina Lyon de Ana; Nicole Ms Smith; Ian Mc Martin; Wesley N Goltry; Alexander Ms Barron; Jeffrey L Browning; Hasmeena Kathuria; Anna C Belkina; Antoine Guillon; Xuemei Zhong; Nicholas A Crossland; Matthew R Jones; Lee J Quinton; Joseph P Mizgerd
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

8.  Human antibody responses to avian influenza A(H7N9) virus, 2013.

Authors:  Li Guo; Xi Zhang; Lili Ren; Xuelian Yu; Lijuan Chen; Hongli Zhou; Xin Gao; Zheng Teng; Jianguo Li; Jiayu Hu; Chao Wu; Xia Xiao; Yiyi Zhu; Quanyi Wang; Xinghuo Pang; Qi Jin; Fan Wu; Jianwei Wang
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

9.  Modified Vaccinia Ankara-Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T Cells in Human Nasopharynx-Associated Lymphoid Tissue.

Authors:  Suttida Puksuriwong; Muhammad S Ahmed; Ravi Sharma; Madhan Krishnan; Sam Leong; Teresa Lambe; Paul S McNamara; Sarah C Gilbert; Qibo Zhang
Journal:  J Infect Dis       Date:  2020-08-04       Impact factor: 5.226

10.  Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.

Authors:  Khalid Shrwani; Ravi Sharma; Madhan Krishnan; Terry Jones; Martin Mayora-Neto; Diego Cantoni; Nigel J Temperton; Susan L Dobson; Krishanthi Subramaniam; Paul S McNamara; Nigel A Cunliffe; Lance Turtle; Qibo Zhang
Journal:  J Infect Dis       Date:  2021-10-28       Impact factor: 5.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.